Santen Pharmaceutical Co., Ltd. Share Price Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
02:49:28 06/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.450 EUR | +2.16% |
|
-2.12% | +6.32% |
| 01/10 | SpyGlass Pharma Acquires Advanced Vision Science for $13 Million | MT |
| 22/09 | Ligand Pharmaceuticals Acquires Ryjunea Royalty Interest for $23 Million | MT |
| Market Cap | 53TCr 337.46Cr 301.05Cr 280.47Cr 255.24Cr 480.66Cr 32TCr 484.22Cr 3.39TCr 1.32TCr 17TCr 1.27TCr 1.24TCr | P/E 2027 * |
13.8x | P/E 2028 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 49TCr 307.88Cr 274.66Cr 255.88Cr 232.86Cr 438.52Cr 30TCr 441.77Cr 3.09TCr 1.2TCr 15TCr 1.16TCr 1.13TCr | EV / Sales 2027 * |
1.6x | EV / Sales 2028 * | 1.46x |
| Free-Float |
96.88% | Yield 2027 * |
2.51% | Yield 2028 * | 2.82% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4536 | Delayed | |
Tradegate
| SZD | Real-time | |
|
Deutsche Boerse AG
| SZD | Delayed | |
|
Börse Stuttgart
| SZD | Delayed | |
|
Boerse Muenchen
| SZD | Real-time |
| 29/23/29 | ETF der Woche: Back to the Roots | |
| 28/23/28 | ETF van de week: terug naar de basis | |
| 28/23/28 | L'ETF della settimana: ritorno ai fondamentali | |
| 28/23/28 | ETF de la semaine : Retour aux fondamentaux | |
| 15/21/15 | Nicox S A : A suivre aujourd'hui |
| 1 week | -2.12% | ||
| Current month | -1.60% | ||
| 1 month | -8.42% | ||
| 3 months | -21.61% | ||
| 6 months | -6.57% | ||
| Current year | +6.32% |
| 1 week | 9.1 |  | 9.45 |
| 1 month | 9.1 | | 9.9 |
| 3 years | 7.8 | | 12 |
| 5 years | 6.4 | | 12.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 01/09/2022 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Daisuke Nakata
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 23/06/2017 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 01/06/2024 |
Rie Nakajima
BRD | Director/Board Member | 48 | 01/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | -2.12% | -0.54% | +8.82% | 337.46Cr | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,01900Cr | |
| -1.21% | -6.99% | +34.08% | +60.96% | 61TCr | |
| +1.12% | -0.20% | +13.62% | +80.24% | 47TCr | |
| -3.30% | -6.15% | +56.45% | +34.69% | 34TCr | |
| +1.71% | +1.66% | +23.13% | +43.13% | 34TCr | |
| +1.55% | -2.10% | +11.89% | +33.94% | 27TCr | |
| +2.65% | -2.82% | -5.09% | +10.38% | 24TCr | |
| -0.01% | -3.62% | +35.28% | +52.02% | 22TCr | |
| -0.08% | -4.98% | +28.34% | +93.61% | 18TCr | |
| Average | +0.86% | -3.63% | +23.33% | +52.89% | 40.92TCr | |
| Weighted average by Cap. | +0.86% | -3.51% | +28.72% | +68.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 30TCr 192.44Cr 171.67Cr 159.94Cr 145.55Cr 274.09Cr 19TCr 276.13Cr 1.93TCr 751.88Cr 9.46TCr 722.4Cr 706.81Cr | 31TCr 197.91Cr 176.56Cr 164.49Cr 149.69Cr 281.9Cr 19TCr 283.99Cr 1.99TCr 773.29Cr 9.73TCr 742.97Cr 726.94Cr |
| Net income | 3.82TCr 24Cr 22Cr 20Cr 18Cr 34Cr 2.33TCr 35Cr 242.92Cr 95Cr 1.19TCr 91Cr 89Cr | 4.08TCr 26Cr 23Cr 21Cr 20Cr 37Cr 2.49TCr 37Cr 259.64Cr 101.02Cr 1.27TCr 97Cr 95Cr |
| Net Debt | -4.67TCr -30Cr -26Cr -25Cr -22Cr -42Cr -2.85TCr -42Cr -297.1Cr -115.59Cr -1.45TCr -111.06Cr -108.66Cr | -7.59TCr -48Cr -43Cr -40Cr -36Cr -68Cr -4.63TCr -69Cr -482.36Cr -187.67Cr -2.36TCr -180.31Cr -176.42Cr |
| Date | Price | Change |
|---|---|---|
| 06/26/06 | €9.350 | +1.08% |
| 05/26/05 | €9.250 | -1.60% |
| 02/26/02 | €9.400 | +0.53% |
| 01/26/01 | €9.350 | -0.53% |
| 30/26/30 | €9.400 | +0.53% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
